Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over Study


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05384678

Organisation Name: University Hospital, Basel, Switzerland

Overal Status: Not yet recruiting

Start Date: September 1, 2022

Last Update: May 20, 2022

Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary: N,N-dimethyltryptamine (DMT) is a psychoactive substance with similar effects such as LSD or psilocybin. However, DMT is less well characterized than the latter substances. The present study is a modern randomized cross-over trial, investigating different continuous intravenous DMT dose rates over a broad dose range. Thus, different doses will be tested and related to subjective and autonomic effects.

Conditions:
  • Healthy


Total execution time in seconds: 0.19301915168762